Bellevue Asset Management, LLC Ptc Therapeutics, Inc. Transaction History

Bellevue Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$33.33 - $44.6 $466 - $624	-14 Reduced 21.21%	52 $2,000
Q4 2021 Feb 03, 2022	SELL	$35.36 - $41.86 $212 - $251	-6 Reduced 8.33%	66 $3,000
Q2 2021 Aug 09, 2021	SELL	$37.95 - $49.37 $303 - $394	-8 Reduced 10.0%	72 $3,000
Q1 2021 May 12, 2021	SELL	$46.8 - $68.92 $280 - $413	-6 Reduced 6.98%	80 $4,000
Q4 2020 Feb 11, 2021	SELL	$47.96 - $67.64 $911 - $1,285	-19 Reduced 18.1%	86 $5,000
Q1 2020 May 13, 2020	BUY	$32.37 - $59.36 $1,650 - $3,027	51 Added 94.44%	105 $6,000
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $1,739 - $2,703	54 New	54 $3,000

227

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.58B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.